Postoperative Nausea and Vomiting. Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Conditions
Interventions
Intervention 1: In the study group (n=150) is infused 10 ml/kg/h Ringer’s solution with 100 mL/h dextrose 10% during surgery. Intervention 2: In the placebo group (n=150) is infused of 10 ml/kg/h Ring
Prevention
Placebo
In the study group (n=150) is infused 10 ml/kg/h Ringer’s solution with 100 mL/h dextrose 10% during surgery.
In the placebo group (n=150) is infused of 10 ml/kg/h Ringer’s solution alone in placebo during surgery.
Sponsors
Vice chancellor for research, Shahroud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ASA class 1; both sexes; aged 18 to 40 years; Open surgeries that are identical in terms of time and type of anesthesia. Exclusion criteria: diabetics; history of systemic disease (cardiovascular, respiratory, renal ,…); history of nausea and vomiting.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of Postoperative Nausea and Vomiting. Timepoint: 0 (while the patient is awake), 30, 60, 120 minute and 4 hours after the surgery. Method of measurement: Questionnaire- Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total dose antiemetic drug. Timepoint: Recovery within 24 hours after surgery. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJavad Nourian MD
Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
Outcome results
None listed